Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FQ3R2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $104,769
Award facts
- Contract value 100% obligated
- $104,769.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $104,769.02 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (quantity: 28 units) with a completion date of September 18, 2025. This competitive, non-set-aside delivery order carries firm fixed pricing and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract was awarded on September 17, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for RINVOQ exemplifies the company's ongoing fulfillment of federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQ3R2?
SPE2DB25FQ3R2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FQ3R2 worth?
The government has obligated $104,769 on SPE2DB25FQ3R2.
Is contract SPE2DB25FQ3R2 an order under another contract?
Yes. SPE2DB25FQ3R2 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ3R2 competed?
The extent of competition for SPE2DB25FQ3R2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award